Genetic Testing Reveals Key Variants in Nonsyndromic Autism Spectrum Disorder in Southern Brazil
Study Explores Genetic Variants in Nonsyndromic ASD
A recent study investigated the effectiveness of chromosomal microarray analysis (CMA) in detecting genetic variants among individuals with clinically nonsyndromic autism spectrum disorder (ASD) in southern Brazil. This research aimed to clarify the diagnostic value of CMA in a population that excludes individuals with syndromic features or major neurological abnormalities.
Diagnostic Yield and Identified Variants
The observational cohort study included 215 participants diagnosed with ASD but without dysmorphic features, known genetic syndromes, significant congenital malformations, epilepsy, or abnormal head size. Using a high-resolution CMA platform (Agilent CGH + SNP Array 180K), researchers identified pathogenic or likely pathogenic copy number variants (CNVs) in six individuals, resulting in a diagnostic yield of 2.8% (95% confidence interval: 1.3-6.1%).
The detected CNVs involved deletions at chromosomal regions 2q11.1-q11.2, 2p16.3 (affecting the NRXN1 gene), 15q11.2 (BP1-BP2), and 3q29, as well as duplications at 16p11.2 and 6p22.3-p22.2. These loci are recognized for their roles in neurodevelopmental processes.
Context and Comparison with Other Cohorts
While the diagnostic yield was lower than that reported in ASD cohorts with more diverse phenotypes, it was consistent with yields observed in similarly selected nonsyndromic groups. This suggests that clinical and phenotypic selection criteria significantly influence the likelihood of identifying pathogenic CNVs through CMA.
Implications for Families and Clinical Practice
The findings indicate that CMA can detect clinically relevant genetic changes even in ASD cases without overt syndromic features. For families, this highlights the potential utility of genetic testing as part of a comprehensive evaluation, although the relatively low detection rate underscores that many cases of nonsyndromic ASD may not be explained by currently identifiable CNVs.
Limitations and Considerations
It is important to note that the study focused on a specific population and excluded individuals with certain clinical features, which may limit the generalizability of the findings. Additionally, the presence of a CNV does not necessarily establish causation for ASD, and further research is required to understand the functional impact of these variants.
For more detailed information, the original study is available at PubMed.
Download the images in this article
